X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10708) 10708
Newspaper Article (233) 233
Magazine Article (152) 152
Newsletter (95) 95
Book Chapter (44) 44
Publication (7) 7
Conference Proceeding (6) 6
Book Review (5) 5
Reference (5) 5
Trade Publication Article (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9133) 9133
science & technology (5259) 5259
life sciences & biomedicine (5121) 5121
diuretics (4905) 4905
female (4432) 4432
male (4356) 4356
diuretics - adverse effects (3557) 3557
diuretics - therapeutic use (3494) 3494
middle aged (3337) 3337
aged (3234) 3234
hypertension - drug therapy (2779) 2779
adult (2155) 2155
hypertension (1996) 1996
cardiovascular system & cardiology (1610) 1610
drug therapy, combination (1368) 1368
antihypertensive agents - therapeutic use (1338) 1338
heart failure (1322) 1322
risk factors (1286) 1286
treatment outcome (1203) 1203
heart failure - drug therapy (1190) 1190
cardiac & cardiovascular systems (1115) 1115
diuretics - administration & dosage (1097) 1097
antihypertensive agents - adverse effects (1053) 1053
blood pressure - drug effects (1030) 1030
blood pressure (983) 983
pharmacology & pharmacy (956) 956
general & internal medicine (935) 935
drug therapy (934) 934
aged, 80 and over (899) 899
angiotensin-converting enzyme inhibitors - therapeutic use (835) 835
medicine, general & internal (822) 822
mortality (783) 783
animals (777) 777
benzothiadiazines (754) 754
adrenergic beta-antagonists - therapeutic use (706) 706
sodium chloride symporter inhibitors - adverse effects (703) 703
patients (701) 701
medicine & public health (697) 697
time factors (673) 673
hypertension - physiopathology (653) 653
care and treatment (652) 652
diuretics - pharmacology (639) 639
double-blind method (601) 601
analysis (582) 582
peripheral vascular disease (562) 562
research (559) 559
hypokalemia - chemically induced (555) 555
retrospective studies (552) 552
sodium chloride symporter inhibitors - therapeutic use (549) 549
hypertension - complications (544) 544
health aspects (530) 530
prospective studies (528) 528
diabetes (525) 525
internal medicine (522) 522
dose-response relationship, drug (516) 516
cardiology (510) 510
calcium channel blockers - therapeutic use (504) 504
clinical trials as topic (496) 496
heart failure - physiopathology (495) 495
furosemide - therapeutic use (494) 494
adolescent (480) 480
follow-up studies (458) 458
furosemide - adverse effects (446) 446
angiotensin-converting enzyme inhibitors - adverse effects (439) 439
clinical trials (436) 436
hydrochlorothiazide - therapeutic use (422) 422
angiotensin (421) 421
antihypertensive agents - administration & dosage (420) 420
potassium - blood (416) 416
cardiovascular disease (409) 409
drug interactions (408) 408
studies (407) 407
abridged index medicus (403) 403
adrenergic beta-antagonists - adverse effects (403) 403
furosemide (397) 397
hydrochlorothiazide - adverse effects (397) 397
urology & nephrology (385) 385
drugs (376) 376
antihypertensive drugs (375) 375
drug dosages (374) 374
enzymes (368) 368
prognosis (368) 368
dosage and administration (363) 363
potassium (350) 350
furosemide - administration & dosage (349) 349
age factors (347) 347
acute disease (339) 339
cardiac patients (336) 336
medicine (332) 332
medical research (331) 331
hydrochlorothiazide (325) 325
cardiovascular (322) 322
randomized controlled trials as topic (321) 321
research article (309) 309
kidney - drug effects (302) 302
kidney diseases (297) 297
complications and side effects (293) 293
drug combinations (293) 293
urine (288) 288
child (282) 282
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9858) 9858
German (438) 438
French (300) 300
Japanese (184) 184
Italian (119) 119
Spanish (117) 117
Russian (98) 98
Danish (55) 55
Norwegian (54) 54
Polish (39) 39
Dutch (35) 35
Portuguese (32) 32
Swedish (24) 24
Hungarian (17) 17
Chinese (14) 14
Czech (13) 13
Bulgarian (11) 11
Hebrew (11) 11
Finnish (10) 10
Romanian (9) 9
Turkish (4) 4
Croatian (2) 2
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastrointestinal endoscopy, ISSN 0016-5107, 2014, Volume 79, Issue 1, pp. 140 - 150
Journal Article
2001, Volume 24, Issue 6, 14
... and valproic acid show mostly beneficial effects on the lipd profile. Some drugs, for example, isotretinoin, acitretin and anti... 
Antihypertensives, adverse reactions | Celiprolol, adverse reactions | Retinol, adverse reactions | Diuretics, adverse reactions | Nelfinavir, adverse reactions | Phenytoin, adverse reactions | Retinoids, adverse reactions | Immunosuppressants, adverse reactions | Calcium channel antagonists, adverse reactions | Danazol, adverse reactions | Progestogens, adverse reactions | Hormonal replacements, adverse reactions | Raloxifene, adverse reactions | Phenobarbital, adverse reactions | Acitretin, adverse reactions | Tamoxifen, adverse reactions | Saquinavir, adverse reactions | Alpha adrenoceptor antagonists, adverse reactions | Carbamazepine, adverse reactions | Oral contraceptives, adverse reactions | Anticonvulsants, adverse reactions | Ritonavir, adverse reactions | Indinavir, adverse reactions | ACE inhibitors, adverse reactions | Estrogens, adverse reactions | Growth hormones, adverse reactions | Protease inhibitors, adverse reactions | Antipsychotics, adverse reactions | Clozapine, adverse reactions | Isotretinoin, adverse reactions | Lipid metabolism disorders, drug-induced | Valproic acid, adverse reactions | Beta adrenoceptor antagonists, adverse reactions | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Selective Estrogen Receptor Modulators - therapeutic use | Humans | Hormones - therapeutic use | Adult | Female | Immunosuppressive Agents - adverse effects | Male | Hormones - adverse effects | Cardiovascular Agents - adverse effects | Hyperlipidemias - chemically induced | Hyperlipidemias - prevention & control
Book Review
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Book Review
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9721, pp. 1173 - 1181
.... We assessed the effects of these drug combinations on progression of chronic kidney disease... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Blood Pressure | Calcium Channel Blockers - adverse effects | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Kidney Failure, Chronic - urine | Male | Albuminuria | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Amlodipine - administration & dosage | Hydrochlorothiazide - adverse effects | Kidney Failure, Chronic - physiopathology | Diuretics - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Risk Factors | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Disease Progression | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Calcium Channel Blockers - administration & dosage | Kidney Failure, Chronic - complications | Creatinine - blood | Hypertension - complications | Aged | Benzazepines - administration & dosage | Diuretics - adverse effects | Drug Combinations | Hypertension | Chronic kidney failure | Patient outcomes | Development and progression | Drug therapy, Combination | Drug therapy | Methods | Risk factors | Studies | Heart failure | Blister packs | Mortality | Kidney diseases | Diabetes | Drugs | blood pressure | Side effects | Filtration | secondary analysis | Dialysis | clinical trials | hypertension | Kidney
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 18, pp. 1887 - 1898
Journal Article